In Silico Assessment of the Radiation Dose Range for Definitive Stereotactic Body Radiation Therapy of Primary Breast Cancer
For definitive stereotactic body radiation therapy for early-stage breast cancer, we propose a dose escalation starting with 45 Gy in 5 fractions to be tested in a clinical trial. Prone position is advised for tumors close to the thoracic cage.
Authors
- I. Frank Ciernik (ORCID: https://orcid.org/0000-0003-2538-9246)
- J. Krayenbuehl
- Shubeen Singh
- Wilfried Budach
- Dirk Vordermark
- Philipp Goldschmidt
- Akash Singh (ORCID: https://orcid.org/0000-0001-9794-8989)
Institutions
- Städtisches Klinikum Dessau (DE)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.adro.2025.101775
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00